Genzyme Mozobil 24mg/1.2mL vials: Missing Lot/Exp Date Risk
Genzyme recalls Mozobil (plerixafor) vials with missing or incorrect lot/expiry dates. This affects prescription-only subcutaneous injections. No immediate action needed but check labels carefully.
Lower-risk recall
Labeling: Incorrect or Missing Lot and/or Exp. Date
Contact the company
What happened, in plain English
Genzyme is recalling Mozobil (plerixafor) injection vials that may have missing or incorrect lot and expiration dates. This could lead to medication errors if the vial's date information is not properly labeled. Read more at govinfonow.com/recall/42498-genzyme-mozobil-24mg-1-2ml-vials-missing-lot-exp-date.
Source Summary by GovInfoNow · govinfonow.com/recall/42498-genzyme-mozobil-24mg-1-2ml-vials-missing-lot-exp-date · Updated October 9, 2026 · FDA enforcement record: FDA #D-1518-2016
Cite this page
“Genzyme Mozobil 24mg/1.2mL vials: Missing Lot/Exp Date Risk.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42498-genzyme-mozobil-24mg-1-2ml-vials-missing-lot-exp-date. Based on FDA recall #D-1518-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1518-2016%22&limit=1).
Why it’s dangerous
Incorrect or missing lot and expiration dates on the vial could lead to medication errors. This might cause patients to use expired or incorrect medication, potentially affecting treatment safety.
Who’s affected
Prescription patients using Mozobil for subcutaneous injections. Those with the specific vial lot number 5RZ002 expiring April 2018 are most at risk.
How to tell if you have this one
Check for vials labeled 'Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial' with lot number 5RZ002 and expiration date 04/18. These were manufactured by Genzyme in the UK.
- Brand
Genzyme- Category
Drug
What to do — step by step
Check Vial Label
Look for the lot number 5RZ002 and expiration date 04/18 on the vial label.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Do I need to stop using Mozobil immediately?
No, the recall only requires checking the label. If the lot number and expiration date are correct, the vial is safe to use.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1518-2016 (August 4, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1518-2016 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.